GEVORKYAN, a.s.
12.1.2026 08:00:00 CET | Globenewswire | Press release
Patria Finance opens new opportunities for investors
Patria Finance opens new opportunities for investors
GEVORKYAN, a.s., listed on the Prague Stock Exchange, welcomes the expansion of the investment group Patria Finance into Slovakia. Slovak investors thus gain another convenient option to purchase GEVORKYAN shares through the local Patria Finance platform, alongside the already available Czech infrastructure.
“Increasing the availability of our shares to investors in the region is an important step for us. After trading in GEVORKYAN shares became available via the online George platform at Česká spořitelna and Slovenská sporiteľňa, another option is now coming to Slovakia in the form of the Patria Finance platform,” says Artur Gevorkyan, Founder and Chairman of the Board of Directors of GEVORKYAN, a.s.
Practical information for investors can be found at www.gevorkyan.eu/en in the “For investors” section.
About GEVORKYAN
GEVORKYAN, a.s. is a leading European company in the field of powder metallurgy, a global supplier to major multinational corporations, and one of the most innovative companies in this industry worldwide. More information can be found at www.gevorkyan.eu/en.
Contact information:
Financial matters: Andrej Bátovský, andrej.batovsky@gevorkyan.sk
Media: Alexandra Hazuchová, marketing@gevorkyan.sk
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Trifork Group AG26.8.2026 17:43:32 CEST | Press release
51/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Scandinavian Tobacco Group A/S26.8.2026 17:20:00 CEST | Press release
Scandinavian Tobacco Group: Interim Report 1 January – 30 June 2026: Progressing with Focus2030 and Full Year 2026 Guidance maintained
Aegon Ltd.26.8.2026 15:50:00 CEST | Press release
Aegon has filed Shareholder Circular for proposed US redomiciliation
ODDIFACT26.8.2026 15:27:59 CEST | Press release
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Værdipapirfonden Independent Invest II26.8.2026 15:03:40 CEST | Pressemeddelelse
Fusion af afdelinger i Værdipapirfonden Independent Invest II
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom